---
figid: PMC8106186__13046_2021_1926_Fig1_HTML
figtitle: Signalling pathways involved in CM, UM and MM oncogenesis, and regulation
  of HIF under hypoxia
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC8106186
filename: 13046_2021_1926_Fig1_HTML.jpg
figlink: pmc/articles/PMC8106186/figure/Fig1/
number: F1
caption: Signalling pathways involved in CM, UM and MM oncogenesis, and regulation
  of HIF under hypoxia. The G protein-coupled receptor (GPCR) and its Gα subunits
  GNAQ and GNA11, downstream activate MEK1/2. The C-X-C chemokine receptor 4 (CXCR4)
  and c-Met activate the mitogen-activated protein kinase (MAPK) signalling pathway,
  consisting of BRAF-MEK1/2-ERK1/2. The KIT receptor activates the PI3K/Akt/mTOR pathway,
  which is influenced by phosphatase and tensin homolog (PTEN), inhibiting  p53. Loss
  of NF1 in melanoma promotes transition of RAS/GDP (inactive state) to its active
  state NRAS/GTP, in turn activating the BRAF-MEK1/2-ERK1/2 and PI3K/Akt/mTOR pathways.
  All of these pathways promote HIF-1α and HIF-2α synthesis and activity. Hypoxia
  drives HIF-1α and HIF-2α stabilization into the nucleus, with consequent induction
  of several genes involved in angiogenesis, survival, metastasization, EMT, drug
  resistance, vasculogenic mimicry through p300/CBP binding to HRE
papertitle: Hypoxia-dependent drivers of melanoma progression.
reftext: Simona D’Aguanno, et al. J Exp Clin Cancer Res. 2021;40:159.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9399468
figid_alias: PMC8106186__F1
figtype: Figure
redirect_from: /figures/PMC8106186__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8106186__13046_2021_1926_Fig1_HTML.html
  '@type': Dataset
  description: Signalling pathways involved in CM, UM and MM oncogenesis, and regulation
    of HIF under hypoxia. The G protein-coupled receptor (GPCR) and its Gα subunits
    GNAQ and GNA11, downstream activate MEK1/2. The C-X-C chemokine receptor 4 (CXCR4)
    and c-Met activate the mitogen-activated protein kinase (MAPK) signalling pathway,
    consisting of BRAF-MEK1/2-ERK1/2. The KIT receptor activates the PI3K/Akt/mTOR
    pathway, which is influenced by phosphatase and tensin homolog (PTEN), inhibiting 
    p53. Loss of NF1 in melanoma promotes transition of RAS/GDP (inactive state) to
    its active state NRAS/GTP, in turn activating the BRAF-MEK1/2-ERK1/2 and PI3K/Akt/mTOR
    pathways. All of these pathways promote HIF-1α and HIF-2α synthesis and activity.
    Hypoxia drives HIF-1α and HIF-2α stabilization into the nucleus, with consequent
    induction of several genes involved in angiogenesis, survival, metastasization,
    EMT, drug resistance, vasculogenic mimicry through p300/CBP binding to HRE
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Oamb
  - twin
  - blo
  - Nf1
  - ras
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pten
  - Akt
  - Erk7
  - rl
  - hy
  - hyx
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Mtor
  - Tor
  - sima
  - tgo
  - CBP
  - nej
  - eIF4E1
  - osa
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - CXCR4
  - KIT
  - NRAS
  - NF1
  - MTG1
  - KRAS
  - HRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - BRAF
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - CDC73
  - KDM5D
  - HIF1A
  - EPAS1
  - HIF3A
  - ARNT
  - ARNT2
  - BMAL1
  - MTOR
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - EP300
  - ITK
  - SLC22A3
  - GDP
  - HIF-1a  HIF-2a  HIF-1B
---
